Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients

Journal of Heart and Lung Transplantation

Volumn 30, Issue 2, 2011, Pages 158-163

  Chin, Clifford ^a   Chen, Ge ^b   Sequeria, Flavia ^b   Berry, Gerald ^b   Siehr, Stephanie ^a   Bernstein, Daniel ^a   Rosenthal, David ^a   Reinhartz, Olaf ^a   Tyan, Dolly ^b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibody mediated rejection; cardiac transplantation; complement; donor specific antibody; HLA antibody; sensitization

Indexed keywords

COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN G ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CHILD; CLINICAL ARTICLE; HEART GRAFT; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INFANT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; COMPLEMENT C1Q; COMPLEMENT FIXATION TESTS; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; INFANT; RETROSPECTIVE STUDIES;

EID: 78650960273     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.08.020     Document Type: Article

References (42)

1. R. Kirk, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: twelfth official pediatric heart transplantation report2009 J Heart Lung Transplant 28 2009 993 1006
2. D.O. Taylor, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report2008 J Heart Lung Transplant 27 2008 943 956
3. U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients OPTN/SRTR 2008 annual report Reported deaths and annual death rates per 1,000 patient-years at risk, 1998 to 2007 heart waiting list http://www.ustransplant.org/annual-reports/current/1103-hr.pdf
4. R.E. Shaddy, and J.A. Hawkins Immunology and failure of valved allografts in children Ann Thorac Surg 74 2002 1271 1275
5. R.E. Shaddy, D.D. Thompson, K.A. Osborne, J.A. Hawkins, and T.C. Fuller Persistence of human leukocyte antigen (HLA) antibodies after one year in children receiving cryopreserved valved allografts Am J Cardiol 1997 80
6. D.K. Hooper, J.A. Hawkins, T.C. Fuller, T. Profaizer, and R.E. Shaddy Panel-reactive antibodies late after allograft implantation in children Ann Thorac Surg 79 2005 641 644 discussion 5
7. A. Brand Immunological aspects of blood transfusions Transpl Immunol 10 2002 183 190
8. K. Lietz, R. John, and A. Kocher Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients Circulation 104 suppl 1 2001 I177 I183
9. M.G. Massad, D.J. Cook, and S.K. Schmitt Factors influencing HLA sensitization in implantable LVAD recipients Ann Thorac Surg 64 1997 1120 1125
10. D.H. McKenna Jr, T. Eastlund, M. Segall, H.J. Noreen, and S. Park HLA alloimmunization in patients requiring ventricular assist support J Heart Lung Transplant 21 2002 1218 1224
11. M.R. Mehra, P.A. Uber, W.E. Uber, R.L. Scott, and M.H. Park Allosensitization in heart transplantation: implications and management strategies Curr Opin Cardiol 18 2003 153 158
12. F.N. Ozdemir, S. Sezer, G. Guz, Z. Arat, M. Turan, and M. Haberal Is hepatitis C virus infection a risk factor for panel-reactive antibody positivity? Transpl Int 13 suppl 1 2000 S31 S33
13. J.M. Rebibou, J. Chabod, and D. Alcalay Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation Transplantation 74 2002 537 540
14. J.C. Stringham, D.A. Bull, and T.C. Fuller Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization J Heart Lung Transplant 18 1999 160 165
15. S.G. Drakos, A.G. Kfoury, and J.R. Kotter Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization J Heart Lung Transplant 28 2009 838 842
16. R. Patel, and P.I. Terasaki Significance of the positive crossmatch test in kidney transplantation N Engl J Med 280 1969 735 739
17. R.A. Bray, L.K. Lebeck, and H.M. Gebel The flow cytometric crossmatch Transplantation 48 1989 834 840
18. R. Pei, G. Wang, and C. Tarsitani Simultaneous HLA class I and class II antibodies screening with flow cytometry Human Immunology 59 1998 313 322
19. J.E. Worthington, A. Langton, H. Liggett, A.J. Robson, and S. Martin A novel strategy for the detection and definition of HLA-specific antibodies in patients awaiting renal transplantation Transpl Int 11 suppl 1 1998 S372 S376
20. H.M. Gebel, and R.A. Bray Sensitization and sensitivity: defining the unsensitized patient Transplantation 69 2000 1370 1374
21. A.R. Tambur, R.A. Bray, and S.K. Takemoto Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection Transplantation 70 2000 1055 1059
22. J.D. Smith, I.M. Hamour, N.R. Banner, and M.L. Rose C4d fixing, luminex binding antibodiesa new tool for prediction of graft failure after heart transplantation Am J Transplant 7 2007 2809 2815
23. V. Aubert, J.P. Venetz, G. Pantaleo, and M. Pascual Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant Hum Immunol 70 2009 580 583
24. F.H. Claas HLA antibody testing: a tool to facilitate not to prevent organ transplantation Int J Immunogenet 35 2008 275 277
25. A. Gupta, and P. Sinnott Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor Hum Immunol 70 2009 618 622
26. D. Phelan, T. Mohanakumar, S. Ramachandran, and M.D. Jendrisak Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay Hum Immunol 70 2009 584 588
27. E.M. van den Berg-Loonen, E.V. Billen, and C.E. Voorter Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients Transplantation 85 2008 1086 1090
28. G. Vlad, E.K. Ho, and E.R. Vasilescu Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival Hum Immunol 70 2009 589 594
29. P.H. Tsau, F.A. Arabia, B. Toporoff, V. Paramesh, G.K. Sethi, and J.G. Copeland Positive panel reactive antibody titers in patients bridged to transplantation with a mechanical assist device: risk factors and treatment ASAIO J 44 1998 M634 M637
30. R. John, K. Lietz, and E. Burke Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients Circulation 100 1999 II229 II235
31. B. Feingold, P. Bowman, and A. Zeevi Survival in allosensitized children after listing for cardiac transplantation J Heart Lung Transplant 26 2007 565 571
32. M.E. Billingham, N.R. Cary, and M.E. Hammond A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group J Heart Lung Transplant 9 1990 587 593
33. S. Stewart, G.L. Winters, and M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710 1720
34. E.F. Reed, A.J. Demetris, and E. Hammond Acute antibody-mediated rejection of cardiac transplants J Heart Lung Transplant 25 2006 153 159
35. H.S. Eng, G. Bennett, P. Bardy, P. Coghlan, G.R. Russ, and P.T. Coates Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools Hum Immunol 70 2009 595 599
36. R. Higgins, M. Hathaway, and D. Lowe Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody Transplantation 84 2007 876 884
37. M.S. Leffell, K. Cao, and M. Coppage Incidence of humoral sensitization in HLA partially mismatched hematopoietic stem cell transplantation Tissue Antigens 74 2009 494 498
38. A.A. Zachary, R.A. Montgomery, and M.S. Leffell Defining unacceptable HLA antigens Curr Opin Organ Transplant 13 2008 405 410
39. J.A. Kobashigawa, A. Sabad, and D. Drinkwater Pretransplant panel reactive-antibody screens Are they truly a marker for poor outcome after cardiac tranplantation? Circulation 94 9 suppl 1996 II294 II297
40. T.C. Fuller, D. Phelan, H.M. Gebel, and G.E. Rodey Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test Transplantation 34 1982 24 29
41. D.M. Lublin, and F.C. Grumet Mechanisms of the CYNAP phenomenon: evidence in the Bw49/Bw50 model for epitopes with different spatial orientation of antibody Hum Immunol 4 1982 137 145
42. J. Kobashigawa, M. Mehra, and L. West Report from a consensus conference on the sensitized patient awaiting heart transplantation J Heart Lung Transplant 28 2009 213 225